Establishment Labs Announces Raj Denhoy Has Joined the Company as Head of Strategy and Investor Relations

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on womena??s health, initially in the breast aesthetics and reconstruction market, announced today that Raj Denhoy has been appointed Head of Strategy and Investor Relations.

Mr. Denhoy will join the executive team at Establishment Labs to help define and execute the companya??s corporate strategy and to communicate that vision to investors and other stakeholders. Mr. Denhoy joins Establishment Labs from Jefferies Group, LLC, where he was a Managing Director and led the US medical device research team for the past eleven years, including coverage of Establishment Labs. He has covered the medical device industry for over twenty years.

"We are grateful to have Raj join our company as we look to become the global market leader in breast aesthetics and reconstruction,a?? said Juan JosA© ChacA?n-QuirA?s, CEO and Founder of Establishment Labs. "His experience and insight will be invaluable as we continue to create value by expanding into new areas of aesthetics.a??

Commenting on his new role, Mr. Denhoy added, "The team at Establishment Labs has accomplished a tremendous amount over the past decade, but what is most compelling is what lies ahead. The continued global roll out of Motiva, the planned launch of the minimally-invasive and market-expanding MIA procedure, and many other innovations to come have created a foundation for significant and sustained value creation. I am excited to be part of realizing that potential.a??

Mr. Denhoy will report directly to CEO Juan JosA© ChacA?n-QuirA?s and will be based in New York City, as Establishment Labs expands its US corporate presence.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Апрель 2021    »